Existing cancer drugs have potential to benefit thousands more patients 31 Jul 2023 Existing targeted cancer drugs could help even more patients, including some with the most common type of breast cancer, scientists have discovered. Find out more Show/Hide
Study shows more women with invasive lobular breast cancer should qualify for tailored clinical trials 30 Mar 2022 A new study led by scientists at The Institute of Cancer Research, London, has changed our understanding of invasive lobular breast cancer – and could increase the number of patients who access new treatments via lobular breast cancer specific clinical trials. Find out more Show/Hide
Researchers find immune system link with rare ovarian cancer that could guide future treatment 14 Oct 2021 Immune-related genes are associated with the development of the rare cancer ovarian clear cell carcinoma (OCCC), new research has found. Find out more Show/Hide
Existing breast cancer drug offers new targeted treatment for triple negative breast cancer 28 Jan 2021